Abstract
Only approximately 12% of drug candidates in clinical trials will reach the market due to unpredicted liabilities in pharmacokinetics, pharmacodynamics, efficacy, and toxicity ([1][1]). Novel techniques, including organs-on-chips, are critical to accelerate drug development and better predict drug
Cite
CITATION STYLE
APA
Yeung, C. K., & Himmelfarb, J. (2019). Kidneys on Chips. Clinical Journal of the American Society of Nephrology, 14(1), 144–146. https://doi.org/10.2215/cjn.06690518
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free